Proteus Syndrome. A case report
Keywords:
segmental growth of a hemibody, hypergrowth of hands and feet, segmental hypergrowth of a limb.Abstract
Introduction: Proteus syndrome, a rare genetic disease, with isolated appearance in all regions. It is characterized by an overgrowth of a region of the body, which can include bones and soft parts, with a preference for hands and feet. This may be accompanied by pigmented linear nevus, lymphangiomas, and deforming hamartomatous tumors that change over time.
Objective: Describe the representative characteristics of a patient with this very rare syndrome using the clinical method.
Case presentation: We present a 5-year-old girl with hypertrophy of the right hemibody, accompanied by extensive pigmented linear nevus, with deforming tumors in different regions including hands and feet.
Conclusions: Due to its rarity, it is difficult to define it clinically, considering it necessary to discuss these cases by a multidisciplinary team to reach the diagnosis after the correct delineation of the phenotype through the clinical method. The use of this instrument is essential to achieve a timely clinical diagnosis and adequate genetic counseling, allowing to guide the follow-up to improve the quality of life of patients.
Downloads
References
REFERENCIAS BIBLIOGRÁFICAS
1. Sachdeva P, Minocha P, Jain R, Sitaraman S, Goyal M. Proteus Syndrome with Neurological Manifestations: A Rare Presentation. J Pediatr Neurosci. 2017 Jan-Mar; 12[citado 4 Sep 2017];31(1):82-90(1):109-111. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28553400.
2. Ou M, Sun Z, Zhu P, Sun G, Dai Y. Proteus syndrome: A case report and review of the literature. Mol Clin Oncol. 2017 Mar;[citado 4 Sep 2019] 6(3):381-383. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28451417.
3. Asilian A, Kamali AS, Riahi NT, Adibi N, Mokhtari F. Proteus Syndrome with Arteriovenous Malformation. Adv Biomed Res. 2017 Mar 7; [citado 4 Sep 2019] 6:27. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28401074.
4. Wu J, Wang Q, Cui P, Wu X, Yan Z. Recurrent cerebriform connective tissue nevus on the foot of a patient with Proteus syndrome. Cutis. 2016 Oct; [citado 4 Sep 2018]98(4):E16-E19. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27874891.
5. Rawal S, Sharma B, Dabla S, Singh J, Goyal S. Proteus Syndrome. J Assoc Physicians India. 2016 May; [citado 4 Sep 2018]64(5):69-71S. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27735155.
6. Nathan N, Keppler-Noreuil KM, Biesecker LG, Moss J, Darling TN. Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway. Dermatol Clin. 2017 Jan;[citado 4 Sep 2019]35(1):51-60. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27890237.
7. Muralidharan V, Vaishak UM, Anjali M, Jayaprakash A. A rare case report of Proteus syndrome. J Assoc Physicians India. 2016 Jan; [citado 4 Sep 2019]64(1):155. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27728734.
8. Keppler-Noreuil KM, Baker EH, Sapp JC, Lindhurst MJ, Biesecker LG. Somatic AKT1 mutations cause meningiomas colocalizing with a characteristic pattern of cranial hyperostosis. Am J Med Genet A. 2016 Oct; [citado 4 Sep 2019]170(10):2605-10. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27550858.
9. Polubothu S, Al-Olabi L, Wilson L, Chong WK, Kinsler VA. Extending the spectrum of AKT1 mosaicism: not just the Proteus syndrome. Br J Dermatol. 2016 Sep;[citado 4 Sep 2019]175(3):612-4. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26872686.
10. Doucet ME, Bloomhardt HM, Moroz K, Lindhurst MJ, Biesecker LG. Lack of mutation-histopathology correlation in a patient with Proteus syndrome. Am J Med Genet A. 2016 Jun; [citado 4 Sep 2019]170(6):1422-1432. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27112325.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).